Deletion of PPARα in mouse brown adipocytes increases their De Novo Lipogenesis

Objective: Peroxisome Proliferator-Activated Receptors (PPARs) are nuclear receptors involved in the control of lipid metabolism. The PPARα isoform is highly expressed in brown adipose tissue (BAT). However, its precise role in BAT remains unclear. Here, we aimed to investigate the role of PPARα in...

Full description

Saved in:
Bibliographic Details
Main Authors: Pierre-Louis Batrow, Sylvie Caspar-Bauguil, Nathalie Rochet, Nadine Gautier, Anne-Sophie Rousseau, Marielle Maret, Samah Rekima, Etienne Mouisel, Emmanuel Van Obberghen, Christian H. Roux, Hervé Guillou, Catherine Postic, Christian Wolfrum, Dominique Langin, Ez-Zoubir Amri, Isabelle Mothe-Satney
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Molecular Metabolism
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877825000912
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849429751001776128
author Pierre-Louis Batrow
Sylvie Caspar-Bauguil
Nathalie Rochet
Nadine Gautier
Anne-Sophie Rousseau
Marielle Maret
Samah Rekima
Etienne Mouisel
Emmanuel Van Obberghen
Christian H. Roux
Hervé Guillou
Catherine Postic
Christian Wolfrum
Dominique Langin
Ez-Zoubir Amri
Isabelle Mothe-Satney
author_facet Pierre-Louis Batrow
Sylvie Caspar-Bauguil
Nathalie Rochet
Nadine Gautier
Anne-Sophie Rousseau
Marielle Maret
Samah Rekima
Etienne Mouisel
Emmanuel Van Obberghen
Christian H. Roux
Hervé Guillou
Catherine Postic
Christian Wolfrum
Dominique Langin
Ez-Zoubir Amri
Isabelle Mothe-Satney
author_sort Pierre-Louis Batrow
collection DOAJ
description Objective: Peroxisome Proliferator-Activated Receptors (PPARs) are nuclear receptors involved in the control of lipid metabolism. The PPARα isoform is highly expressed in brown adipose tissue (BAT). However, its precise role in BAT remains unclear. Here, we aimed to investigate the role of PPARα in BAT of high fat diet-induced obese mice in a thermoneutral environment. Methods: We used tamoxifen-inducible-BAT specific PPARα knockout mice (PPARαBATKO) that were housed at thermoneutrality to minimize BAT basal activation, fed a high-fat diet for 20 weeks and challenged with a β3-adrenergic agonist (CL316,243) during the last week. Both male and female mice were studied. Results: Body weight and glucose tolerance tests were similar in both sexes and genotypes. However, BAT morphology was altered in PPARαBATKO mice, with more unilocular and larger lipid droplets compared to control mice, suggesting BAT impaired function. Indeed, when treated with CL316,243, both male and female mice had increased De Novo Lipogenesis (DNL), reflected by an increased expression of ChREBPβ and lipogenic enzymes ACLY, ACC1, FASN and SCD1. These changes were accompanied by an increase in fatty acids in triglycerides, and thus an increase in lipid storage. Moreover, lipid profiles in phospholipids were different, suggesting a modification in the membrane content with an increase of palmitoleate. Conclusions: Altogether, our results reveal a key role for PPARα in DNL in BAT and in the regulation of lipid metabolism in HFD-induced obesity.
format Article
id doaj-art-6f55fd36feb14dde9cb0f836f5ab4832
institution Kabale University
issn 2212-8778
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series Molecular Metabolism
spelling doaj-art-6f55fd36feb14dde9cb0f836f5ab48322025-08-20T03:28:14ZengElsevierMolecular Metabolism2212-87782025-08-019810218410.1016/j.molmet.2025.102184Deletion of PPARα in mouse brown adipocytes increases their De Novo LipogenesisPierre-Louis Batrow0Sylvie Caspar-Bauguil1Nathalie Rochet2Nadine Gautier3Anne-Sophie Rousseau4Marielle Maret5Samah Rekima6Etienne Mouisel7Emmanuel Van Obberghen8Christian H. Roux9Hervé Guillou10Catherine Postic11Christian Wolfrum12Dominique Langin13Ez-Zoubir Amri14Isabelle Mothe-Satney15Université Côte d’Azur, CNRS, Inserm, Adipocible Research Study Group, Institut de Biologie Valrose (iBV), Nice, FranceInstitute of Metabolic and Cardiovascular Diseases, I2MC, University of Toulouse, Inserm, Toulouse III University - Paul Sabatier (UPS), Toulouse, France; Department of Medical Biochemistry, Toulouse University Hospitals, FranceUniversité Côte d’Azur, CNRS, Inserm, Adipocible Research Study Group, Institut de Biologie Valrose (iBV), Nice, FranceUniversité Côte d’Azur, CNRS, Inserm, Adipocible Research Study Group, Institut de Biologie Valrose (iBV), Nice, FranceUniversité Côte d’Azur, CNRS, Inserm, Adipocible Research Study Group, Institut de Biologie Valrose (iBV), Nice, FranceUniversité Côte d’Azur, CNRS, Inserm, IRCAN, Nice, FranceUniversité Côte d’Azur, CNRS, Inserm, Adipocible Research Study Group, Institut de Biologie Valrose (iBV), Nice, FranceInstitute of Metabolic and Cardiovascular Diseases, I2MC, University of Toulouse, Inserm, Toulouse III University - Paul Sabatier (UPS), Toulouse, FranceUniversité Côte d’Azur, CNRS, Laboratoire de PhysioMédecine Moléculaire (LP2M), Laboratories of Excellence Ion Channel Science and Therapeutics, Nice, FranceUniversité Côte d’Azur, CNRS, Inserm, Adipocible Research Study Group, Institut de Biologie Valrose (iBV), Nice, France; Rheumatology Department, Hospital Pasteur 2 CHU, Adipocible Research Study Group, 06000, Nice, FranceToxalim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, FranceUniversité Paris Cité, Institut Cochin, CNRS, Inserm, Paris, FranceLaboratory of Translational Nutrition Biology, Institute of Food, Nutrition and Health, ETH Zurich, Schwerzenbach, SwitzerlandInstitute of Metabolic and Cardiovascular Diseases, I2MC, University of Toulouse, Inserm, Toulouse III University - Paul Sabatier (UPS), Toulouse, France; Department of Medical Biochemistry, Toulouse University Hospitals, France; Institut Universitaire de France (IUF), Paris, FranceUniversité Côte d’Azur, CNRS, Inserm, Adipocible Research Study Group, Institut de Biologie Valrose (iBV), Nice, FranceUniversité Côte d’Azur, CNRS, Inserm, Adipocible Research Study Group, Institut de Biologie Valrose (iBV), Nice, France; Corresponding author. Institut de Biologie Valrose, Université Côte d’Azur, CNRS UMR 7277, Inserm U1091, Tour Pasteur, Faculté de Médecine, 28, Avenue de Valombrose, 06107, Nice, France.Objective: Peroxisome Proliferator-Activated Receptors (PPARs) are nuclear receptors involved in the control of lipid metabolism. The PPARα isoform is highly expressed in brown adipose tissue (BAT). However, its precise role in BAT remains unclear. Here, we aimed to investigate the role of PPARα in BAT of high fat diet-induced obese mice in a thermoneutral environment. Methods: We used tamoxifen-inducible-BAT specific PPARα knockout mice (PPARαBATKO) that were housed at thermoneutrality to minimize BAT basal activation, fed a high-fat diet for 20 weeks and challenged with a β3-adrenergic agonist (CL316,243) during the last week. Both male and female mice were studied. Results: Body weight and glucose tolerance tests were similar in both sexes and genotypes. However, BAT morphology was altered in PPARαBATKO mice, with more unilocular and larger lipid droplets compared to control mice, suggesting BAT impaired function. Indeed, when treated with CL316,243, both male and female mice had increased De Novo Lipogenesis (DNL), reflected by an increased expression of ChREBPβ and lipogenic enzymes ACLY, ACC1, FASN and SCD1. These changes were accompanied by an increase in fatty acids in triglycerides, and thus an increase in lipid storage. Moreover, lipid profiles in phospholipids were different, suggesting a modification in the membrane content with an increase of palmitoleate. Conclusions: Altogether, our results reveal a key role for PPARα in DNL in BAT and in the regulation of lipid metabolism in HFD-induced obesity.http://www.sciencedirect.com/science/article/pii/S2212877825000912Peroxisome proliferator-activated receptor alphaBrown adipose tissueInducible UCP1-CREHigh fat diet-induced obesityβ3-adrenergic stimulationLipid metabolism
spellingShingle Pierre-Louis Batrow
Sylvie Caspar-Bauguil
Nathalie Rochet
Nadine Gautier
Anne-Sophie Rousseau
Marielle Maret
Samah Rekima
Etienne Mouisel
Emmanuel Van Obberghen
Christian H. Roux
Hervé Guillou
Catherine Postic
Christian Wolfrum
Dominique Langin
Ez-Zoubir Amri
Isabelle Mothe-Satney
Deletion of PPARα in mouse brown adipocytes increases their De Novo Lipogenesis
Molecular Metabolism
Peroxisome proliferator-activated receptor alpha
Brown adipose tissue
Inducible UCP1-CRE
High fat diet-induced obesity
β3-adrenergic stimulation
Lipid metabolism
title Deletion of PPARα in mouse brown adipocytes increases their De Novo Lipogenesis
title_full Deletion of PPARα in mouse brown adipocytes increases their De Novo Lipogenesis
title_fullStr Deletion of PPARα in mouse brown adipocytes increases their De Novo Lipogenesis
title_full_unstemmed Deletion of PPARα in mouse brown adipocytes increases their De Novo Lipogenesis
title_short Deletion of PPARα in mouse brown adipocytes increases their De Novo Lipogenesis
title_sort deletion of pparα in mouse brown adipocytes increases their de novo lipogenesis
topic Peroxisome proliferator-activated receptor alpha
Brown adipose tissue
Inducible UCP1-CRE
High fat diet-induced obesity
β3-adrenergic stimulation
Lipid metabolism
url http://www.sciencedirect.com/science/article/pii/S2212877825000912
work_keys_str_mv AT pierrelouisbatrow deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT sylviecasparbauguil deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT nathalierochet deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT nadinegautier deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT annesophierousseau deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT mariellemaret deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT samahrekima deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT etiennemouisel deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT emmanuelvanobberghen deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT christianhroux deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT herveguillou deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT catherinepostic deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT christianwolfrum deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT dominiquelangin deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT ezzoubiramri deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis
AT isabellemothesatney deletionofpparainmousebrownadipocytesincreasestheirdenovolipogenesis